See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2023_CTI_Biopharma_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI Biopharma CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 99,396,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 23,226,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,303,000 |
| 4 | LiabilitiesCurrent | 81,134,000 |
| 5 | LiabilitiesNoncurrent | 1,234,000 |
| 6 | remainder_Liabilities | 61,134,000 |
| 7 | CostOfGoodsAndServicesSold | 2,306,062 |
| 8 | SellingGeneralAndAdministrativeExpense | 112,090,805 |
| 9 | ResearchAndDevelopmentExpense | 36,016,901 |
| 10 | remainder_Expenses | 4,241,752 |
| 11 | remainder_Revenues | 36,097,773 |
| 12 | remainder_NetIncome | -11,187,297 |
| 13 | remainder_ComprehensiveNetIncome | -28,485 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 125,925,000 |
| 1 | Liabilities | 143,502,000 |
| 2 | Expenses | 154,655,520 |
| 3 | Revenues | 36,097,773 |
| 4 | StockholdersEquity | -17,577,000 |
| 5 | NetIncome | -129,745,044 |
| 6 | ComprehensiveNetIncome | -129,759,286 |
| 7 | BaseVar | 235,698,038 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.25 |
| 9 | EconomicCapitalRatio | 1.25 |
Edgar->Model Mapping
Feature Distribution
Change over Time
